Clinical Study
Minimally Invasive Transforaminal Lumbar Interbody Fusion at L5-S1 through a Unilateral Approach: Technical Feasibility and Outcomes
Table 3
Lumbopelvic parameters.
| | | Preoperative | Immediate postoperative | 6 months | 12 months |
| | DH | 7.0 ± 1.9 (3.6–11.1) | 8.8 ± 1.8 (5.8–12.8) | 8.2 ± 1.4 (5.7–10.9) | 7.8 ± 1.3 (6.0–10.2) | | SLA | 13.3 ± 4.3 (6.1–21.1) | 16.5 ± 4.9 (9.1–23.4) | 15.6 ± 5.9 (8.5–23.1) | 15.5 ± 4.4 (7.5–23.2) | | LLA | 44.3 ± 12.3 (23.9–71.9) | 48.6 ± 12.8 (24.6–82) | 47.6 ± 13.9 (25.6–77) | 47.1 ± 13.2 (26.9–76.3) | | DA | 8.8 ± 3.5 (1.7–14.2) | 10.8 ± 3.05 (4.8–15) | — | — | | DSA | 30.5 ± 7.7 (20.6–46.4) | — | — | — | | PI | 54.7 ± 9.7 (33.5–57.5) | 54.3 ± 8.8 (32.2–61.6) | — | — | | PT | 18.9 ± 9.9 (9.1–39.4) | 17.4 ± 8.8 (6–29.1) | — | — | | SS | 34.1 ± 6.9 (22.6–44.3) | 35.2 ± 8.1 (18.9–49.2) | | | | Fusion rate | — | — | 67.7 | 95.2 | | Endplate violation/cage subsidence (cumulative) | — | 5 | 6 | 7 |
|
|
